Clinical Trial Update: Postmarketing Safety Surveillance European Registry of Crohn's Disease Patients Treated With Remicade or Standard Therapy (MK-2155-035)

View source ↗

Summary

A European postmarketing safety surveillance registry evaluated outcomes for Crohn's disease patients treated with Remicade (infliximab) versus standard therapy…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Crohn Disease

Drugs mentioned

• Remicade (infliximab)

Snippet

Sponsor: Merck Sharp & Dohme LLC | Conditions: Crohn's Disease | Status: COMPLETED | Results posted: 2014-08-26